GLP-1 Prior Auths: Which Path, Submitted Where
A quick routing guide for nurses and prescriber offices, from your friends at West Wichita Family Pharmacy. The #1 source of delays we see: the request goes to the wrong destination. Match your patient below.
Commercial insurance (any indication)
Standard PA to the patient's plan — submit through CoverMyMeds, Surescripts, or your EHR exactly as you would any PA. Nothing special.
Two clicks that save everyone calls: when submitting in CoverMyMeds, opt the patient into status notifications (enter their cell with consent) so they're texted the outcome directly. And remind the patient to grab the manufacturer savings card — most commercially covered patients pay ~$25/month with it. Our patient tool walks them through it: wwfrx.com/glp1
Medicare + weight management → the Bridge
This one does NOT go to the Part D plan. The Medicare GLP-1 Bridge (effective July 1, 2026) has its own prior authorization submitted to the CMS central processor on a dedicated form:
- Form: cms.gov/glp-1-bridge.pdf
- Full instructions: CMS provider information page
Patient must fit the Bridge profile: enrolled in Part D (or MA-PD); BMI ≥35, or ≥30 with a qualifying comorbidity; GLP-1-naïve through Part D; and no type 2 diabetes, moderate-to-severe OSA, or MASH diagnosis (those have their own coverage paths — see below). Covered products: Wegovy (all forms), Zepbound KwikPen, Foundayo. Patient pays a flat $50/month at the pharmacy once approved.
A Bridge request sent to the Part D plan — or a plan-style coverage determination sent to CMS — will bounce. Wrong-destination submissions are the delay we see most.
Medicare + type 2 diabetes → regular Part D
Prescribe the diabetes-labeled sibling (Ozempic or Mounjaro) and run a standard coverage determination / PA with the patient's Part D plan — the ordinary process, through the plan, not CMS. Same story for Zepbound prescribed for obstructive sleep apnea: that indication goes through the plan's normal PA, not the Bridge.
No coverage → no PA at all
Skip the paperwork entirely — the patient buys direct at set cash prices (NovoCare Pharmacy for Wegovy, LillyDirect for Zepbound, or TrumpRx.gov). Send the e-script to the manufacturer's pharmacy per their instructions, or send it to us and we'll counsel the patient on the cheapest route.
Keeping track & following up
- Log every submission the same way: patient, drug, pathway (plan PA vs. Bridge), destination, and date sent. A simple spreadsheet beats memory — the pathway column is what prevents re-submitting to the wrong place.
- Commercial & Part D: statuses live in your CoverMyMeds dashboard/EHR queue. Turn on patient notifications at submission so outcomes reach the patient without a phone call.
- Bridge requests: track via the CMS processor's confirmation; check anything pending past a week and re-verify it went to the processor, not the plan.
- Close the loop with the pharmacy: when an approval lands, a quick e-script or fax note to us means the patient's first fill is ready before they call anyone.
Questions? Call us at 316-491-6428 — we untangle these daily and are glad to help your staff route a tricky one.
Current as of August 2026. Program rules are set by CMS, the plans, and the manufacturers and change frequently — verify against the linked official sources. This page is general workflow information, not billing, legal, or medical advice.